Teleflex Incorporated $TFX Shares Sold by Vanguard Group Inc.

Vanguard Group Inc. cut its stake in shares of Teleflex Incorporated (NYSE:TFX) by 0.8% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 4,759,015 shares of the medical technology company’s stock after selling 37,795 shares during the quarter. Vanguard Group Inc. owned about 0.11% of Teleflex worth $580,790,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also made changes to their positions in TFX. Empowered Funds LLC increased its stake in Teleflex by 15.8% in the 1st quarter. Empowered Funds LLC now owns 1,684 shares of the medical technology company’s stock valued at $233,000 after purchasing an additional 230 shares in the last quarter. Jane Street Group LLC boosted its position in Teleflex by 42.6% during the first quarter. Jane Street Group LLC now owns 6,343 shares of the medical technology company’s stock worth $877,000 after purchasing an additional 1,895 shares in the last quarter. American Century Companies Inc. boosted its position in Teleflex by 32.7% during the second quarter. American Century Companies Inc. now owns 13,640 shares of the medical technology company’s stock worth $1,614,000 after purchasing an additional 3,360 shares in the last quarter. Invesco Ltd. boosted its position in Teleflex by 1.2% during the second quarter. Invesco Ltd. now owns 135,516 shares of the medical technology company’s stock worth $16,040,000 after purchasing an additional 1,659 shares in the last quarter. Finally, EverSource Wealth Advisors LLC boosted its position in Teleflex by 108.1% during the second quarter. EverSource Wealth Advisors LLC now owns 1,003 shares of the medical technology company’s stock worth $119,000 after purchasing an additional 521 shares in the last quarter. 95.62% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

TFX has been the topic of a number of research reports. Wall Street Zen raised shares of Teleflex from a “sell” rating to a “hold” rating in a research note on Saturday, April 25th. Royal Bank Of Canada restated a “sector perform” rating on shares of Teleflex in a report on Tuesday, April 14th. Needham & Company LLC raised their target price on shares of Teleflex from $138.00 to $147.00 and gave the company a “buy” rating in a report on Thursday, February 26th. Bank of America upgraded shares of Teleflex from an “underperform” rating to a “neutral” rating and set a $135.00 target price for the company in a report on Monday, April 13th. Finally, Weiss Ratings restated a “sell (d)” rating on shares of Teleflex in a report on Friday, March 27th. Two research analysts have rated the stock with a Buy rating, six have given a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of $133.57.

Teleflex Price Performance

Teleflex stock opened at $120.02 on Tuesday. Teleflex Incorporated has a 12-month low of $100.18 and a 12-month high of $139.67. The stock has a market capitalization of $5.31 billion, a P/E ratio of -5.84, a P/E/G ratio of 0.88 and a beta of 0.82. The firm’s 50-day moving average is $118.74 and its two-hundred day moving average is $116.72. The company has a debt-to-equity ratio of 0.81, a current ratio of 2.54 and a quick ratio of 2.01.

Teleflex (NYSE:TFX) last released its quarterly earnings results on Thursday, February 26th. The medical technology company reported $1.93 earnings per share (EPS) for the quarter, missing the consensus estimate of $3.73 by ($1.80). Teleflex had a positive return on equity of 14.30% and a negative net margin of 30.56%.The firm had revenue of $569.00 million for the quarter, compared to analyst estimates of $912.57 million. During the same period in the prior year, the business earned $3.89 earnings per share. Teleflex’s revenue for the quarter was down 28.5% on a year-over-year basis. Teleflex has set its FY 2026 guidance at 6.250-6.550 EPS. Equities analysts predict that Teleflex Incorporated will post 6.77 earnings per share for the current year.

Teleflex Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, March 31st. Shareholders of record on Friday, March 6th were paid a dividend of $0.34 per share. This represents a $1.36 annualized dividend and a dividend yield of 1.1%. The ex-dividend date of this dividend was Friday, March 6th. Teleflex’s dividend payout ratio (DPR) is currently -6.62%.

Teleflex Profile

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.